InvestorsHub Logo
Followers 24
Posts 4945
Boards Moderated 0
Alias Born 07/18/2006

Re: Cpap21 post# 445832

Thursday, 01/04/2024 9:37:47 AM

Thursday, January 04, 2024 9:37:47 AM

Post# of 463626
Anavex’s press release states that CHMP/EMA has deemed Blarcamesine eligible for submission of a MAA. A number of posters have concluded that the data have already been reviewed, implying that the submission is a mere formality and that approval is all but assured. This is factually wrong. The process of submitting a MAA and having the MAA reviewed by European regulators is a long, difficult process, and a positive outcome is not assured.

Pumpers like Georgejjl would have you believe that this is a slam dunk, just like they’d have you believe that institutions are loading up on AVXL (implying that the smart money institutions believe approval is imminent). Please take what they say with a grain of salt and recognize that the pumpers are not altruists.

Shareholders, myself included, are certainly hoping for approval in the EU. But let’s be realistic. This is a long and difficult process with no certainty of success. If you can tolerate a high degree of risk in part of your portfolio, by all means hold AVXL. Just be careful about acting on advice from people who stand to gain personally from trafficking in misinformation and disinformation.

Good luck in your investing.

Good licks and DOG bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News